help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearce, E. N.
Right arrow Articles by Braverman, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearce, E. N.
Right arrow Articles by Braverman, L. E.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 12 5499-5502
Copyright © 2002 by The Endocrine Society


COMMENT

Effects of Chronic Iodine Excess in a Cohort of Long-Term American Workers in West Africa

Elizabeth N. Pearce, A. Russell Gerber, David B. Gootnick, Laura Kettel Khan, Ruowei Li, Sam Pino and Lewis E. Braverman

Section of Endocrinology, Diabetes, and Nutrition, Boston Medical Center, Boston University School of Medicine (E.N.P., S.P., L.E.B.), Boston, Massachusetts 02118; Peace Corps Office of Medical Services (A.R.G.), Washington, D.C. 20526; U.S. General Accounting Office (D.B.G.), Washington, D.C. 20008; National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention (L.K.K., R.L.), Atlanta, Georgia 30341

Address all correspondence and requests for reprints to: Lewis E. Braverman, M.D., Section of Endocrinology, Diabetes, and Nutrition, Boston Medical Center, 88 East Newton Street, Evans 201, Boston, Massachusetts 02118. E-mail: lewis.braverman{at}bmc.org.

Abstract

A cross-sectional survey of 102 Peace Corps volunteers in Niger, West Africa, in 1998 had previously demonstrated a high rate of thyroid dysfunction and goiter attributable to excess iodine from their water filters. The Peace Corps volunteers were followed-up a mean of 30 wk after they ceased using iodine-based water filtration systems. Goiter was present in 44% of subjects during excess iodine ingestion and in 30% after removal of excess iodine. Mean serum iodine decreased from 293 µg/liter during excess iodine ingestion to 84 µg/liter after cessation of excess iodine. Mean total serum T4 values increased from 100.4 to 113.3 nmol/liter (7.8 to 8.8 µg/dl). Mean serum free T4 increased from 32.2 to 34.7 pmol/liter (2.5 to 2.7 ng/dl). Mean serum TSH decreased from 4.9 to 1.8 mU/liter. Mean serum thyroid peroxidase antibody levels decreased from 33,000 to 22,000 IU/liter (33 to 22 IU/ml).

We found that during prolonged excess iodine exposure there were marked increases in serum total iodine concentrations, and the prevalence of goiter, elevated serum TSH values, and elevated serum thyroid peroxidase antibody values increased. The prevalence of all abnormalities decreased after removal of excess iodine from the drinking water system.

PEACE CORPS VOLUNTEERS in Niger, West Africa, were noted to have a high prevalence of goiter from 1995–1998. Initial investigation revealed 39 suspected cases of thyroid abnormality. Peace Corps volunteers in many areas of Africa drink iodine-enriched water to avoid microbial contamination, and it was subsequently found that the two-stage iodine-resin ceramic filters in use in Niger delivered a mean concentration of 10 mg iodine/liter to the drinking water (1). There was no evidence of a high concentration of iodine in the diet, salt, medications, or nutritional supplements.

As the arid climate in Niger results in the daily consumption of 5–9 liters water, the volunteers consumed at least 50 mg iodine daily, which is approximately 300 times the daily U.S. Recommended Dietary Allowance (2). Urinary iodine excretion in this iodine-enriched population ranged from 392–153,780 µg/liter (median, 5,048 µg/liter). Volunteers used the water purification devices described above for up to 32 months. After the discovery of this iodine overload, all iodine-based filters in Niger were discontinued, and other methods of purification were used (boiling the water or treating the water with microfiltration and chlorine purification).

In May 1998, a cross-sectional survey of volunteers then in Niger was conducted just before removal of the excess iodine from the drinking water and, on the average, 30 ± 11 wk later (range, 3–83 wk) in Niger or after return to the U.S. Goiter prevalence and levels of serum TSH and thyroid peroxidase (TPO) antibodies significantly decreased after removal of the water filters and correction of the iodine excess, strongly suggesting that the iodine-induced abnormalities were not permanent.

Subjects and Methods

Study population

Of the 103 Peace Corps volunteers in Niger in May of 1998, 102 (99%) participated in the survey, and 1 declined. Data describing 96 of these subjects have been previously published (1). Volunteers were young (mean age, 25.5 ± 3.0 yr) and predominantly female (75%). All Peace Corps volunteers were authorized to receive a follow-up evaluation by an endocrinologist after returning from Niger. Some follow-up evaluations were incomplete, as some of the subjects chose not to visit an endocrinologist upon returning, and different endocrinologists obtained different follow-up laboratory studies. The cumulative total dose of iodine ingested by each volunteer could not be determined, as iodine consumption varied depending on length of stay in Niger, the frequency of water filter changes, and the amount of water consumed.

Assessment of goiter

The presence or absence of goiter was assessed by palpation by two physicians before correction of the iodine excess. Goiter size was graded per WHO recommendations (3); the least severe classification was assigned in the five cases where observers disagreed. The presence or absence of goiter was evaluated again an average of 30 wk after correction of the iodine excess. Ultrasound evaluation was not performed.

Laboratory studies

Serum TSH, T4, and free T4 levels were determined by chemiluminescence immunometric assays (performed by Quest Laboratories, Teterboro, NJ). Normal ranges were as follows: TSH, 0.40–4.20 mU/liter; T4, 58–154 nmol/liter (4.50–12.0 µg/dl); and free T4, 22.5–49 pmol/liter (1.75–3.80 ng/dl). TPO antibody levels were measured by ELISA (American Laboratory Products Co., Ltd., Lindham, NH), with normal values below 20,000 IU/liter (<20 IU/ml). Total serum iodine concentrations (normal range, 45–100 µg/liter) were measured spectrophotometrically by a modification of the method of Benotti et al. (4). Thyroid function tests and serum iodine concentrations were carried out upon completion of the study in most, but not all, subjects.

Statistical analysis

Most quantitative data were compared using paired sample t tests. A signed-rank test was used to determine differences between TSH values during and after excess iodine exposure. McNemar’s paired sample {chi}2 test was used to compare the presence or absence of goiter during and after excess iodine exposure. A {chi}2 test was used to assess associations between elevated TPO antibody levels and goiter and between elevated TPO antibody levels and elevated serum TSH values. Unless otherwise specified, data are presented as the mean ± SD. All P values are two-tailed. Significance was indicated by P < 0.05.

Results

Goiter prevalence

Ninety-three of the 102 subjects had clinical thyroid evaluation both during and after excess iodine ingestion. Thyroid ultrasound was not performed. Goiter was present in 41 of the subjects (44%) during iodine ingestion, and prevalence apparently decreased to 28 of these 93 subjects (30%) after removal of excess iodine (P < 0.001; Table 1Go). However, thyroid palpation was performed by different examiners at the follow-up visit. No volunteers had overt symptoms of thyroid dysfunction as evaluated clinically.


View this table:
[in this window]
[in a new window]
 
Table 1. Thyroid parameters during and after excess iodine exposure

 
Serum iodine

Fifty-one of the 102 volunteers had total serum iodine levels measured during and after excess iodine exposure. Mean serum iodine decreased from 293 ± 306 to 84 ± 46 µg/liter (P < 0.0001).

Serum T4 and free T4

Eighty-eight of the 102 volunteers had total serum T4 values measured during and after excess iodine exposure. Mean total serum T4 values increased from 100.4 ± 20.6 nmol/liter (7.8 ± 1.6 µg/dl) to 113.3 ± 24.5 nmol/liter (8.8 ± 1.9 µg/dl; P = 0.002). Eighty-seven of the volunteers had serum free T4 values measured during and after excess iodine ingestion. Serum free T4 increased from a mean of 32.2 ± 6.4 pmol/liter (2.5 ± 0.5 ng/dl) to 34.7 ± 6.4 pmol/liter (2.7 ± 0.5 ng/dl; P = 0.01).

Serum TSH

Ninety of the volunteers had serum TSH values measured before and after excess iodine ingestion. During iodine ingestion the geometric mean for serum TSH values was 2.63 mU/liter, which significantly decreased after removal of the excess iodine to 1.07 mU/liter (P < 0.0001). Serum TSH was greater than 4.2 mU/liter in 29% of 100 volunteers during iodine ingestion, which decreased to 5% of the 90 volunteers after removal of the excess iodine. Serum TSH values were less than 0.4 mU/liter in 5 of 90 volunteers (6%) during iodine ingestion and in 13 of 90 (14%) after removal of excess iodine (P < 0.05). Serum TSH values were suppressed below the limits of the assay (<0.02 mU/liter) in only a single subject during excess iodine ingestion; that subject had a TPO antibody level of 5700 IU/liter (5.7 IU/ml), serum iodine level of 255 µg/liter, and no goiter. That subject’s TSH had normalized to 1.97 at a 16 wk follow-up exam. It is unknown whether any treatment for a thyroid condition occurred in the interval between exams. TSH levels were also suppressed in a second subject 25 wk after removal of excess iodine. That subject had an initial TSH value of 1.7 mU/liter, an initial anti-TPO antibody level of 1900 IU/liter (1.9 IU/ml), and an initial serum iodine level of 180 µg/liter. A goiter was present at both the initial and follow-up exams. No follow-up anti-TPO antibody level was obtained, and further clinical information about this subject was unavailable.

Serum TPO antibodies

Serum TPO antibodies were above 20,000 IU/liter (>20 IU/ml) in 14 of 100 volunteers (14%) during excess iodine ingestion. TPO antibody values greater than 20,000 IU/liter were not significantly associated with the presence of goiter (P = 0.75) or with serum TSH levels of more than 5 mU/liter (P = 0.55). Fifty-two of those volunteers had follow-up TPO antibody measurements, and of those, only 4 (8%) had antibody levels greater than 20,000 IU/liter. When the mean TPO antibody values during and after iodine ingestion were compared in those 52 volunteers, there was a significant decrease from 32,800 ± 128,900 to 21,900 ± 104,700 IU/liter (P < 0.01). The groups with and without follow-up TPO antibody measurements appeared to be relatively similar, with 7 of 52 subjects (13%) in the group with follow-up values and 7 of 48 subjects (15%) in the group without follow-up TPO antibody levels having initial TPO antibody values greater than 20,000 IU/liter.

Discussion

Previously published reports have described both subclinical and overt thyroid dysfunction as a result of excess iodine ingestion. Goiter, hypothyroidism, and/or a rise in serum TSH values have been reported to result from ingestion of excess iodine in medications such as amiodarone (5), as a natural contaminant of drinking water (6), as a byproduct of iodine-containing water purification systems (7, 8, 9, 10), in iodine-containing mouth rinses (11), and in the diet (seaweed ingestion) (12). Individuals with underlying autoimmune thyroid disease, those with a previous history of postpartum thyroiditis or subacute thyroiditis, or patients who have undergone partial thyroidectomy have all been shown to be prone to iodine-induced goiter and hypothyroidism (13). Additionally, although the natural history of thyroid dysfunction related to acute excess iodine ingestion has been well characterized, the effects of chronic iodine excess remain poorly understood.

Acute excess iodine ingestion has long been known to result in a transient decrease in iodine organification, termed the acute Wolff-Chaikoff effect (14). With sustained excess iodine exposure, however, most individuals’ thyroid glands escape from this acute Wolff-Chaikoff effect despite continued excess iodine exposure and resume synthesis of normal amounts of T4 and T3. The mechanism responsible for this escape or adaptation to the iodine load probably involves a decrease in the Na+/I- symporter protein, resulting in a decrease in thyroid iodide content (15). In some individuals this escape phenomenon does not occur, and those patients develop iodine-induced hypothyroidism. Such hypothyroidism generally is reversible when the source of excess iodine exposure is removed.

In this study inadvertent excess iodine ingestion from the water purification system by Peace Corps volunteers in Niger for up to 32 months between 1995 and 1998 resulted in a variety of thyroid abnormalities. During the prolonged excess iodine exposure there were marked increases in serum total iodine concentrations, and the prevalence of goiter, elevated serum TSH values, and elevated serum TPO antibody values increased. The prevalence of all abnormalities decreased after removal of excess iodine from the drinking water system.

There was a high prevalence of goiter among Peace Corps volunteers in this study at baseline in both euthyroid and hypothyroid individuals. Although an increase in thyroid size in the presence of excess iodine ingestion has been noted previously (16, 17), the mechanism for goiter formation remains unclear. It has been suggested that an increase in lymphoid infiltration or a mild chronic rise in TSH may be responsible. In one histological study of the thyroid glands of 28 Japanese patients chronically exposed to excess dietary iodine, 13 had lymphocytic infiltration, and 25 had moderate to marked follicular hyperplasia (12).

Although individuals with underlying autoimmune thyroid disease are more likely to develop complications of excess iodine ingestion, it is unclear whether excess iodine ingestion itself can lead to autoimmune disease. Animal studies have suggested that excess iodine exposure predisposes to the development of autoimmune thyroid disease (18). However, controversy exists about whether there is a relationship between excess iodine ingestion and the development of Hashimoto’s thyroiditis in humans (19). It has been observed that in areas of Japan where dietary iodine intake is high, the incidence of Hashimoto’s thyroiditis is higher than in areas of low to normal dietary iodine intake (20). An increase in lymphocytic infiltration often occurs after iodine repletion in iodine-deficient regions (21). However, other studies have failed to show a relationship between increased iodine intake and autoimmunity (22, 23). In this study some Peace Corps volunteers had anti-TPO antibodies during excess iodine exposure. These abnormal TPO antibody titers decreased in some, but not all, subjects when excess iodine was eliminated. This suggests that excess iodine ingestion may induce thyroid autoimmunity in an otherwise healthy young population.

The findings in this study have significant public health implications. In 1998, an estimated 60,000 iodine resin devices and 300,000 bottles of iodine tablets were sold to U.S. civilians for water disinfection (24). In addition, iodine-based water purification systems are routinely used by the military, in international relief efforts, and by other government-sponsored programs. In this regard we have recently reported that excess iodine ingestion by American astronauts from water treated with iodine for purification in space resulted in a small transient rise in serum TSH values upon return to earth (25). Since 1998, the iodine has been removed from astronauts’ potable water by an anion exchange resin just before the water is consumed, and no rise in serum TSH values has been observed. It is probably inadvisable for pregnant women, individuals with a history or a strong family history of thyroid disease, especially autoimmune thyroid disease, or individuals residing in areas of endemic iodine deficiency to use iodine-based methods of water purification unless extremely careful monitoring of the iodine content is carried out. Any individual anticipating prolonged ingestion of excess amounts of iodine in medications or as a byproduct of a water purification system should see a physician for a baseline physical exam to exclude the presence of preexisting goiter and to measure thyroid function tests and serum thyroid antibody levels to rule out abnormalities. Repeat thyroid function tests should then be repeated at intervals until excess iodine ingestion is eliminated.

Acknowledgments

Footnotes

Abbreviations: TPO, Thyroid peroxidase.

Received May 3, 2002.

Accepted September 17, 2002.

References

  1. Khan LK, Li R, Gootnick D, Peace Corps Thyroid Investigation Group 1998 Thyroid abnormalities related to excess iodine from water purification units. Lancet 352:1519[CrossRef][Medline]
  2. National Research Council 1989 Recommended dietary allowances, 10th Ed. Report of the Subcommittee on the 10th Edition of the RDAs. Food and Nutrition Board, Commission on Life Sciences, National Research Council. Washington DC: National Academy Press
  3. WHO, UNICEF, ICCIDD 2001 Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers, 2nd Ed. Geneva: WHO/NHD; 01.1
  4. Benotti J, Benotti N, Pino S, Gardyna H 1965 Determination of total iodine in urine, stool, diets and tissue. Clin Chem 11:932–936[Abstract]
  5. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240–254[Abstract/Free Full Text]
  6. Zhao J, Chen Z, Maberly G 1998 Iodine-rich drinking water of natural origin in China. Lancet 352:2024
  7. Liel Y, Alkan M 1996 "Travelers’ thyrotoxicosis:" transitory thyrotoxicosis induced by iodinated preparations for water purification. Arch Intern Med 156:807–810[Abstract]
  8. Mueller B, Diem P, Burgi U 1998 "Travelers’ thyrotoxicosis" revisited. Arch Intern Med 158:1723[Free Full Text]
  9. Georgitis WJ, McDermott MT, Kidd GS 1993 An iodine load from water-purification tablets alters thyroid function in humans. Mil Med 158:794–797[Medline]
  10. LeMar HJ, Georgitis WJ, McDermott MT 1995 Thyroid adaptation to chronic tetraglycine hydroperiodide water purification tablet use. J Clin Endocrinol Metab 80:220–223[Abstract]
  11. Ader AW, Paul TL, Reinhardt W, Safran M, Pino S, McArthur W, Braverman LE 1988 Effect of mouth rinsing with two polyvinylpyrrolidone-iodine mixtures on iodine absorption and thyroid function. J Clin Endocrinol Metab 66:632–635[Abstract]
  12. Mizukami Y, Michigishi T, Nonomura A, Hashimoto T, Tonami N, Matsubara F, Takazakura E 1993 Iodine-induced hypothyroidism: a clinical and histological study of 28 patients. J Clin Endocrinol Metab 76:466–471[Abstract]
  13. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG 2001 Iodine-induced hypothyroidism. Thyroid 11:501–510[CrossRef][Medline]
  14. Wolff J, Chaikoff IL 1948 Plasma inorganic iodide as homeostatic regulator of thyroid function. J Biol Chem 174:555–564[Free Full Text]
  15. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE 1999 Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404–3410[Abstract/Free Full Text]
  16. Namba H, Yamashita S, Kimura H, Yokoyama N, Usa T, Otsuru A, Izumi M, Nagataki S 1993 Evidence of thyroid volume increase in normal subjects receiving excess iodide. J Clin Endocrinol Metab 76:605–608[Abstract]
  17. Suzuki H, Higuchi T, Sawa K, Ohtaki S, Horiuchi Y 1975 Endemic coast goiter in Hokkaido, Japan. Acta Endocrinol (Copenh) 50:161–176
  18. Ruwhof C, Drexhage HA 2001 Iodine and thyroid autoimmune disease in animal models. Thyroid 11:427–436[CrossRef][Medline]
  19. Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L, Andersen S 2001 Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 11:457–469[CrossRef][Medline]
  20. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K 1994 Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Endocrinol Metab 78:393–397[Abstract]
  21. Harach HR, Williams ED 1995 Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clin Endocrinol (Oxf) 43:701–706[Medline]
  22. Boyages SC, Bloot AM, Maberly GF, Eastman CJ, Mu L, Qidong Q, Derun L, van der Gaag RD, Drexhage HA 1989 Thyroid autoimmunity in endemic goiter caused by excessive iodine intake. Clin Endocrinol (Oxf) 31:453–465[Medline]
  23. Martins MC, Lima N, Knobel M, Medeiros-Neto G 1989 Natural course of iodine-induced thyrotoxicosis (JodBasedow) in endemic goiter area: a 5 year follow up. J Endocrinol Invest 12:329–344[Medline]
  24. Backer H, Hollowell J 2000 Use of iodine for water disinfection: iodine toxicity and maximum recommended dose. Environ Health Perspect 108:679–684[Medline]
  25. McMonigal KA, Braverman LE, Dunn JT, Stanbury JB, Wear ML, Hamm PB, Sauer RL, Billica RD, Pool SL 2000 Thyroid function changes related to use of iodinated water in the U.S. Space Program. Aviat Space Environ Med 71:1120–1125[Medline]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. B Zimmermann, Y. Ito, S. Y Hess, K. Fujieda, and L. Molinari
High thyroid volume in children with excess dietary iodine intakes
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 840 - 844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Andersen, B. Hvingel, K. Kleinschmidt, T. Jorgensen, and P. Laurberg
Changes in iodine excretion in 50-69-y-old denizens of an Arctic society in transition and iodine excretion as a biomarker of the frequency of consumption of traditional Inuit foods
Am. J. Clinical Nutrition, March 1, 2005; 81(3): 656 - 663.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearce, E. N.
Right arrow Articles by Braverman, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearce, E. N.
Right arrow Articles by Braverman, L. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals